Skip to main content
Springer logoLink to Springer
. 2023 Jun 9;43(7):1671–1672. doi: 10.1007/s10875-023-01531-6

Correction to: PEGylated Recombinant Adenosine Deaminase Maintains Detoxification and Lymphocyte Counts in Patients with ADA-SCID

Morna J Dorsey 1,, Arye Rubinstein 2, Heather Lehman 3, Tracy Fausnight 4, Joseph M Wiley 5, Elie Haddad 6,
PMCID: PMC10499941  PMID: 37294519

Correction to : Journal of Clinical Immunology

https://doi.org/10.1007/s10875-022-01426-y

The original version of this article contained an error in Table 4 under “total number of hospitalizations”. The corresponding information in the text was correct. The corrected table is presented below:

Table 4.

Summary of infections and hospitalizations

Elapegademase
N = 7
Patients with infection, n (%) 5 (71.4)
Total number of infections, n 26
Patients with hospitalization, n (%) 3 (42.9)
Total number of hospitalizations, n (%)
    1 2 (28.6)
    2 1 (14.3)
    3 0 (0.0)
Duration of hospitalization, days
    n 4
    Mean 5.0
    SD 2.16
    Median 5.5
    Min 2
    Max 7
Reason for hospitalization, na
    Dehydration 1
    Hemoptysis 1
    Respiratory tract infection 1
    Tooth abscess 1
     Vestibular migraine 1

Duration of hospitalization = (end date of hospitalization – start date) + 1.

aPatients can be admitted more than once so “n” can be larger than the number of patients, and row totals can sum to more than the number of patients

Max, maximum, Min, minimum, SD, standard deviation.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Morna J. Dorsey, Email: Morna.Dorsey@ucsf.edu

Elie Haddad, Email: elie.haddad@umontreal.ca.


Articles from Journal of Clinical Immunology are provided here courtesy of Springer

RESOURCES